President Joe Biden announced that his administration is on track to have enough anti-coronavirus vaccine supply for every adult in the United States by the end of May.
To achieve this target, Johnson & Johnson will work with Merck to expand the production of the single-shot coronavirus vaccine developed by its vaccine division, Janssen Biotech.
Subscribe to continue reading the article.
This article is part of our premium content offering.Subscribe with a RTTNews subscription.
Subscribe NowAlready subscribed? Sign in
For comments and feedback: editorial@rttnews.com